Eurofarma is a Brazilian multinational pharmaceutical company engaged in biopharmaceuticals. Eurofarma is currently seeking validated targets, novel compounds, and/or adjuvant compounds for antibacterial drugs/therapies.
Approaches of Interest
- The highest priority is given to opportunities involving validated targets and small molecule drugs, synthetics and natural products are also within scope, but there is less interest in peptide-based approaches
- Priority will be given to bactericidal compounds, however, bacteriostatic and adjuvant compounds are also...